Literature DB >> 2245691

Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock.

R L Danner1, C Natanson, R J Elin, J M Hosseini, S Banks, T J MacVittie, J E Parrillo.   

Abstract

We investigated the effects of two different Gram-negative bacteria and radiation-induced leukopenia on endotoxemia, cardiovascular abnormalities, and mortality in a canine model of septic shock. Serial hemodynamics were measured in conscious dogs using radionuclide heart scans and thermodilution cardiac output catheters. Plasma endotoxin concentrations were determined with a chromogenic Limulus amebocyte lysate assay. Viable Pseudomonas aeruginosa or Escherichia coli implanted intraperitoneally produced concordant hemodynamic patterns of septic shock (p less than 0.01). Endotoxin concentrations were more than tenfold lower in dogs infected with P aeruginosa compared with E coli (p less than 0.0001). Despite lower endotoxin levels, P aeruginosa-infected dogs had a higher mortality (p less than 0.01), more severe hypotension (p less than 0.05), and greater depression of the left ventricular ejection fraction (p less than 0.05) than dogs with E coli sepsis. A nonlethal E coli challenge combined with leukopenia (induced by a nonlethal dose of radiation) resulted in a mortality of 60 percent (p less than 0.01) without greater cardiovascular dysfunction or higher endotoxin concentrations. These findings suggest that bacterial products other than endotoxin and host-related factors may be important contributors to the toxicity, cardiovascular instability, and mortality of Gram-negative septic shock. Quantitative determinations of plasma endotoxin are unlikely to correlate with the clinical severity of septicemia in heterogeneous patient populations infected with different Gram-negative organisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2245691     DOI: 10.1378/chest.98.6.1480

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

1.  Endotoxemia as a diagnostic tool for patients with suspected bacteremia caused by gram-negative organisms: a meta-analysis of 4 decades of studies.

Authors:  James C Hurley; Piotr Nowak; Lars Öhrmalm; Charalambos Gogos; Apostolos Armaganidis; Evangelos J Giamarellos-Bourboulis
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

Review 2.  Mechanisms in acute septic cardiomyopathy: evidence from isolated myocytes.

Authors:  K Werdan; U Müller; C Reithmann; A Pfeifer; S Hallström; B Koidl; G Schlag
Journal:  Basic Res Cardiol       Date:  1991 Sep-Oct       Impact factor: 17.165

3.  Reappraisal with meta-analysis of bacteremia, endotoxemia, and mortality in gram-negative sepsis.

Authors:  J C Hurley
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

Review 4.  Antibiotic-induced release of endotoxin. A therapeutic paradox.

Authors:  J C Hurley
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

Review 5.  Immunotherapy in the management of sepsis.

Authors:  E A Fagan; M Singer
Journal:  Postgrad Med J       Date:  1995-02       Impact factor: 2.401

Review 6.  Antiendotoxin monoclonal antibodies. What future now?

Authors:  G M Susla; R B Dew
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

Review 7.  Clinical relevance of antibiotic-induced endotoxin release.

Authors:  J M Prins; S J van Deventer; E J Kuijper; P Speelman
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

8.  Does gram-negative bacteraemia occur without endotoxaemia? A meta-analysis using hierarchical summary ROC curves.

Authors:  J C Hurley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-29       Impact factor: 3.267

9.  Metformin protects against infection-induced myocardial dysfunction.

Authors:  Theodora Tzanavari; Aimilia Varela; Stamatis Theocharis; Elpinickie Ninou; Alkistis Kapelouzou; Dennis V Cokkinos; Maria I Kontaridis; Katia P Karalis
Journal:  Metabolism       Date:  2016-07-09       Impact factor: 8.694

Review 10.  Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.

Authors:  Jeffrey L Veesenmeyer; Alan R Hauser; Thiago Lisboa; Jordi Rello
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.